Login / Signup

Association of alpha-1-adrenergic antagonist use with the risk of gout development in benign prostatic hyperplasia patients: a population-based cohort study.

Wei-Hung HsuJung-Nien LaiCheng-Li LinChing-Hui LohHuei-Kai HuangLiang-Kai Huang
Published in: Family practice (2022)
Patients who received more doses of alpha-1-adrenergic antagonists per year had a higher risk of developing gout. A causal proof of the role of alpha-1-adrenergic antagonists use in gout development should be analysed in future studies designed as double blind randomized controlled trials.
Keyphrases